Drawing for BIOSITEHISTO OPTIBODIES

USPTO serial 86004143

BIOSITEHISTO OPTIBODIES

Reviewed by CopyMark Law Group

Reg. 4571000Status 710
Filing date
Status date
Registration date
Jul 22, 2014
Examiner
DELGIZZI, RONALD ERNEST
Law office
TMEG LAW OFFICE 107

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIOSITEHISTO OPTIBODIES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Hynak

Michael J. Hynak HYNAK & ASSOCIATES, PC812 S COURTHOUSE RDARLINGTON, VA 22204-2105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry, science and photography; chemicals used in agriculture, horticulture and forestry, namely, chemical preparations for the treatment of seeds; adhesives for industrial use; amino acids for industrial purposes; biochemicals, namely, polypeptides for in vitro research use; biochemicals namely, precursors for in vitro genetic engineering use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; stem cells for research or scientific purposes; reagents for scientific purposes; reagents for scientific or medical research use; reagents in kit form for conducting enzyme-linked immunosorbent assays, other than for medical or veterinary purposes; monoclonal antibodies for scientific use; chemical linking agents for scientific use in associating antibodies with radionuclides; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical linkage compounds for scientific use in associating X-ray radiodiagnostic chemical compounds with antibodies; chemical components for producing a radio-labelled monoclonal antibody for industrial or scientific use; tagged antibodies for laboratory use; monoclonal antibodies for scientific use; reagents for scientific or medical research use; proteins for use in science; chemical preparations for use in dna analysis, other than for medical use; enzymes for scientific purposes; enzymes for technical use; enzymes, not for medical use, for detecting protein fractions; enzymes, not for medical use, for labelling protein fractions; enzymes, not for medical use, for labelling proteins; enzymes, not for medical use, for measuring protein fractions; enzymes, other than for medical use, for measuring proteins; enzymes, not for medical use, for use in detecting proteins; enzymes, not for medical or veterinary use; enzymes, not for medical use, for use in the continuous homogenous isothermal amplifications of specific dna templates; enzymes not for medical use, for use in the continuous homogenous isothermal amplifications of specific rna templates; immunological antibodies, other than for medical use; immunoglobulins, other than for medical use; Immunological antisera, other than for medical use; immunoassay reagents, other than for medical use; chemical reagents for use with immunoassay analyzers, other than for medical or veterinary use; chemicals for use in immuno-assay testing, other than medical or veterinary; tagged antibodies for laboratory use; amino acids for industrial purposes; antibodies, namely, mono or polyclonal antibodies for detection of neuronal or glial indications for scientific or research useSECTION 8 - CANCELLED—
005Sanitary preparations for medical purposes; dietary supplements for humans and animals; plasters, materials for dressings; disinfectants; preparations for destroying vermin, namely, fungicides and herbicides; antibodies, namely, monoclonal antibodies for medical research and diagnostics to produce and or create proteins in blood, serum, plasma or tissue; human immune globulin, namely, immune globulin for medical research and diagnostics to produce and or create proteins in blood, serum, plasma or tissue; serums, namely, serums for medical research and diagnostics to produce and or create protein in blood, plasma or tissue; amino acids for veterinary purposes; chemical preparation for use in medical dna analysis in the nature of nucleic acids; enzymes for medical purposes; enzymes for veterinary purposesSECTION 8 - CANCELLED—
042Scientific and technological services, namely, scientific research, research and design, analysis, testing in the field of medical research and diagnostics in connection with proteins in the blood, serum, plasma or tissue; industrial analysis and research services; design and development of computer hardware and software; laboratory services relating to the production of monoclonal antibodies; development of pharmaceutical preparations and medicines; laboratory services; research on the subject of pharmaceuticals; pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development servicesSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 13, 2021NCS8NOTICE OF CANCELLATION SEC. 8 EMAILED—
Apr 12, 2021C8..CANCELLED SEC. 8 (6-YR)—
Oct 8, 2020PRA8POST REGISTRATION ACTION MAILED - SEC. 8—
Oct 8, 2020APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 9, 2020ES8RTEAS SECTION 8 RECEIVED—
Jul 22, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 22, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 6, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 6, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 16, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 29, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 27, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 21, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 19, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 5, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 5, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2014ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 10, 2014PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 25, 2014PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 23, 2014ALIEASSIGNED TO LIE—
Dec 30, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 30, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Dec 30, 2013GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 30, 2013GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 30, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 12, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 12, 2013ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Oct 24, 2013GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Oct 24, 2013GNSLLETTER OF SUSPENSION E-MAILED—
Oct 24, 2013CNSLSUSPENSION LETTER WRITTEN—
Oct 19, 2013DOCKASSIGNED TO EXAMINER—
Jul 16, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 11, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance